Madison Square Garden (MSGS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Madison Square Garden (MSGS) reported Q4 revenue of $203.96 million, a 10.3% year-over-year decline, yet significantly surpassed consensus estimates by 23.1%. EPS of -$0.07 also beat expectations by 83.33%. This beat was largely driven by event-related revenue of $140.32 million, which substantially exceeded analyst projections despite a 7.8% annual decrease. However, MSGS shares have returned -4.3% over the past month against the S&P 500's +3.1%, and the stock carries a Zacks Rank #5 (Strong Sell), signaling potential near-term underperformance despite the reported earnings surprise.

Analysis

Madison Square Garden (MSGS) reported mixed Q4 2025 results, characterized by significant beats against consensus estimates but notable year-over-year declines in fundamental performance. Revenue of $203.96 million and EPS of -$0.07 surpassed analyst expectations by 23.1% and 83.33%, respectively. This outperformance was primarily driven by event-related revenue, which came in at $140.32 million, far exceeding the $88.37 million average estimate. However, this positive surprise is tempered by broad-based weakness compared to the prior year. Overall revenue fell 10.3% year-over-year, and the company swung to a loss from a profit of $1.06 per share in the year-ago quarter. Critically, every major revenue segment detailed in the report posted a year-over-year decline, including a severe 66.8% drop in league distributions. The market appears to be weighing these negative trends more heavily than the earnings beat, as reflected in the stock's -4.3% return over the past month and its current Zacks Rank #5 (Strong Sell), signaling a cautious near-term outlook.

Key Decisions for Investors

• Investors should look past the headline earnings beat, which was driven by low expectations, and focus on the significant year-over-year deterioration across all key revenue segments.
• Given the stock's recent underperformance relative to the S&P 500 and the explicit Zacks Rank #5 (Strong Sell) rating, maintaining a cautious or bearish stance on MSGS may be prudent in the near term.
• Monitor future performance in the 'League distributions' and 'Event-related' revenue streams, as a reversal of their negative year-over-year trends is necessary to justify a more constructive outlook.